Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Enveda Therapeutics, Inc.
DBA/AKA/TA/Formerly
DBA Enveda Therapeutics, Inc.
INTERNAL ADDRESS
5777 Crowntree Lane
*MAILING ADDRESS
Apt 202
*CITY
Orlando
*STATE
(Required for U.S. applicants)
Florida
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
32829
PHONE
415-323-5252
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
*IDENTIFICATION
BIOEDGE represents a technology platform that integrates multi-omics data for mechanism of action and biomarker discovery.
FILING BASIS
SECTION 1(b)
CORRESPONDENCE INFORMATION
NAME
Enveda Therapeutics, Inc.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
viswa.colluru@envedatx.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
daniel.wee@envedabio.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEES DUE
275
*TOTAL FEES PAID
275
SIGNATURE INFORMATION
SIGNATURE
/VISWA COLLURU/
SIGNATORY'S NAME
Viswa Colluru
SIGNATORY'S POSITION
CEO
SIGNATORY'S PHONE NUMBER
415-323-5252
DATE SIGNED
12/10/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:90373531
Filing Date:12/10/2020
To the Commissioner for Trademarks:
MARK: BIOEDGE (Standard Characters, see mark)
The literal element of the mark consists of BIOEDGE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Enveda Therapeutics, Inc., DBA Enveda Therapeutics, Inc., a corporation of Delaware, having an address of
5777 Crowntree Lane
Apt 202
Orlando, Florida 32829
United States
415-323-5252(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class _______: BIOEDGE represents a technology platform that integrates multi-omics data for mechanism of action and biomarker discovery.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /VISWA COLLURU/ Date: 12/10/2020
Signatory's Name: Viswa Colluru
Signatory's Position: CEO
Payment Sale Number: 90373531
Payment Accounting Date: 12/10/2020
Serial Number: 90373531
Internet Transmission Date: Thu Dec 10 18:37:08 ET 2020
TEAS Stamp: USPTO/BAS-XX.X.XXX.XXX-20201210183708917
203-90373531-7503c698ddf757916b69e373708
92fc8257af1917a8d7ea52a29e025a25da0d6d5-
CC-37065230-20201210175357762370